Pss36 - Pharmacoeconomic Evaluation of Pharmacological Treatment Options for Patients With Moderately-Severe and Severe Psoriasis With Base Therapy Resistance

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2536
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Treatment of Severe Psoriasis With Infliximab

Therapeutics and Clinical Risk Management
2008English

Pharmacoeconomic Analysis of Therapy With Reslizumab in Severe Eosinophilic Asthma

Pulmonologiya
PulmonaryRespiratory Medicine
2018English

Costs of Treatment in Patients With Moderate to Severe Plaque Psoriasis

Archives of Dermatology
2004English

Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis

JAMA Dermatology
DermatologyMedicine
2020English

Methylprednisolone Pulse Therapy for Patients With Moderately Severe Graves' Orbitopathy: A Prospective, Randomized, Placebo-Controlled Study

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2008English

Experience With the Systemic Treatment of Severe Forms of Psoriasis

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
BiochemistryMedicineGeneticsMolecular Biology
2012English

22B. Integrative Therapy for Patients With Severe Tinnitus

Global Advances In Health and Medicine
Medicine
2013English

Prevalence of Advanced Liver Fibrosis in Patients With Severe Psoriasis

JAMA Dermatology
DermatologyMedicine
2019English

Successful Treatment of Severe Psoriasis Vulgaris in Child With Methotrexate Injection

Dermatology Reports
Dermatology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy